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Glucocorticoids  have  a  major  role  in  the  therapy  of  inflammatory  and 
immunologically mediated diseases. The precise mechanism of the suppressive 
and anti-inflammatory effects of these drugs is still unknown, but the functions 
of the mononuclear phagocyte system are generally believed to be sensitive to 
glucocorticoid action (1-3). During glucocorticoid administration in vivo, mono- 
cytopenia occurs (4-6) and monocytes fail to accumulate at inflammatory sites 
(7-10).  In  the  presence  of glucocorticoids,  macrophages  do  not  respond  to 
macrophage  migration  inhibitory factor  (11),  and  fail  to  become "armed" or 
activated (8,  11-13).  In experiments in vivo it is difficult to determine whether 
glucocorticoids are acting directly on macrophages or indirectly on lymphocytes 
and other cells that produce mediators of macrophage function (3, 8). 
Macrophages may serve as a direct target for the therapeutic actions of anti- 
inflammatory steroids. In the accompanying paper (14), I establish that mono- 
nuclear phagocytes contain specific, high affinity receptors for glucocorticoids. 
In the  present paper,  I  examine the  action of glucocorticoids on biochemical 
functions of monocytes and macrophages cultured in vitro. Mononuclear phag- 
ocytes at all stages of maturation are sensitive to glucocorticoids. Production of 
monocytic  and  granulocytic  colonies  from  bone  marrow  precursors  and  the 
secretion of elastase, collagenase, plasminogen activator, and nonspecific neu- 
tral proteinases by mature macrophages are inhibited by physiological concen- 
trations  of glucocorticoids.  I  have  studied  macrophages  from  glucocorticoid- 
sensitive  (rabbit,  mouse)  and  glucocorticoid-insensitive (human,  guinea  pig) 
species, and all show similar glucocorticoid-mediated actions, even though they 
differ  in  hormone-mediated  effects  on  lymphocytes  (1,  3).  Because  steroid 
concentrations comparable to those for saturating the high affinity glucocorti- 
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coid binding  sites  suppress  macrophage  secretion  and  colony  formation,  it  is 
likely that these effects are mediated by specific glucocorticoid receptors. 
Materials and Methods 
Cells.  Human blood monocytes, adjuvant-induced rabbit pulmonary alveolar macrophages, 
resident  mouse  peritoneal  macrophages,  and  thioglycollate-elicited mouse  peritoneal  macro- 
phages were obtained as described in the accompanying paper (14). Pulmonary alveolar macro- 
phages from unstimulated guinea pigs were obtained by lavage procedures similar to those used 
for rabbits (14, 15). 
Cell  Culture.  Mouse  macrophages were  cultured  in  Dulbecco's  modified  Eagle's  medium 
(DME) 1 supplemented with 10% fetal calf serum (FCS) in 16-mm-diameter multiwell dishes for 
24-48  h  before experiments. The  cultures were washed 4  times with  DME.  Unless otherwise 
indicated, the cells were then cultured in DME supplemented with 0.2% lactalbumin hydrolysate 
(DME-LH)  (14,  16). Cortisol and  steroids of similar solubility were  dissolved at  ~0.1  mM  in 
phosphate-buffered  saline, and their concentrations were determined spectrophotometrically (14); 
less soluble steroids were dissolved in 100% ethanol at -~0.1 mM and added to cultures to a final 
concentration of <1% ethanol. Freshly prepared steroid solutions were added to culture media 
just before use. 
Human monocytes (0.5-1.0 ×  10s/16-mm well) were cultured on l~I-labeled fibrin plates (14, 17) 
in DME +  10% FCS containing 60 ~g of soybean trypsin inhibitor (STI)/ml for 24-48 h. The cells 
were then washed 4 times with DME, and the medium was replaced with DME-LH or DME + 5% 
dog serum that had been acid-treated and plasminogen-depleted (ATDS-P) (17,  18) with steroids 
and with or without added dog plasminogen (1-30 nM). 
Rabbit and guinea pig alveolar macrophages (0.5-1.0 × 10~/16-mm dish) were cultured in DME- 
LH alone for 24-48  h; the medium was then replaced with fresh DME-LH containing steroids as 
required 
Determination of Bone Marrow Colony Formation.  Formation of monocytic and granulocytic 
colonies (CFU-C) from bone marrow precursor cells was determined by culturing 5  ×  104 bone 
marrow cells from adult Swiss mice (CF-1; Charles River Breeding Laboratories, Inc., Wilming- 
ton,  Mass.) in agar with L-cell colony-stimulating factor (19). Half-maximum concentrations of 
colony-stimulating activity were used in these experiments, and dexamethasone was added when 
the plates were poured.  Colony number and type were determined at 7 and 14  days of culture; 
colonies contained at least 50  cells,  and clusters contained fewer than 50  cells.  Colonies were 
scored as being granulocytic, monocytic, or mixed. 
Metabolic Experiments.  Phagocytosis of 1.1-tLm-diameter latex particles or sheep erythrocytes 
coated with 7S immunoglobulin G from rabbit anti-serum to sheep erythrocytes was studied as 
described previously (13, 16, 20). Metabolism of  glucose to CO2 was measured by standard methods 
(12). For studies of protein synthesis, macrophages were incubated with 5 t~Ci of [~sS]methionine/ 
ml in methionine-free DME, and the amount of cell-associated isotope that was precipitable in 5~ 
trichloroacetic acid was determined. 
Enzyme Assays.  Lysozyme was assayed with Micrococcus lysodeikticus cell walls as substrate 
(211 and compared with egg white lysozyme standards. 
Collagenase was measured with reconstituted l~C-labeled guinea pig skin collagen fibrils as 
substrate (16L Samples of conditioned medium were activated before assay by treatment with 
chloromethyl ketone-treated trypsin  (TPCK)-trypsin  /10  tLg/ml,  30  min  at  25°C),  followed by 
addition of a  fivefold excess of STI  (18L  1 U  of collagenase activity hydrolyzed 1 tLg of collagen 
fibrils/min at 37°C. 
Elastase was assayed quantitatively by measuring release of peptides from [:~H]NaBH4-reduced 
elastin in the presence of the hydrophobic ligand, sodium dodecyl sulfate (SDSI  I17). For routine 
assays, tubes contained 200  t~g of elastin and 50  ~g of SDS in  100 mM Tris-HC1 buffer, pH 7.6, 
' Abbreviations  used  in  this  paper:  ATDS-P,  dog  serum  that  has  been  acid-treated  and 
plasminogen-depleted; CFU-C, colony-forming units from bone marrow stem cells; DME,  Dul- 
becco's modified Eagle's medium; DME-LH, DME supplemented with 0.2% lactalbumin hydroly- 
sate; FCS, fetal calf serum; K~, half-maximum concentration; SDS, sodium dodecyl sulfate; STI, 
soybean trypsin inhibitor; TPCK, chloromethyl ketone-treated trypsin. ZENA  WERB  1697 
containing 5 mM CaCl~, and 25-200 t~l of conditioned culture medium in a final volume of 300 ttl. 
The release of labeled peptides by elastases was linear to ~40% of the total available radioactive 
elastin determined by complete hydrolysis with porcine pancreatic elastase.  Assays were  incu- 
bated for 4-24 h  as required.  1 U  of elastase hydrolyzed 1 tLg of elastin/h at 37°C.  Elastase was 
also determined qualitatively by radial diffusion of conditioned medium samples in elastin-SDS- 
agarose plates (17, 22). 
Plasminogen activator was measured in several ways.  Cells were grown on plates coated with 
~SI-labeled fibrin, and the release of labeled peptides was monitored (171. Plasminogen activator 
was also measured in conditioned medium and cell lysates by the fibrin plate assay (17), by direct 
observation of conversion of l~SI-plasminogen to plasmin heavy and light chains (9), and by single- 
cell assays (13).  1 U  of plasminogen activator solubilized 5% of the available ~I-fibrin/h in the 
presence of plasminogen (~1 tLg/h at 37°C ~. 
For assay of nonspecific neutral  proteinases,  conditioned culture  medium  was incubated on 
~-'SI-labeled fibrin-coated plates in 50 mM Tris-HC1 buffer, pH 7.6, without plasminogen, and the 
release of radioactive peptides was measured.  1 U  of proteolytic activity solubilized 1 tLg of l~sI- 
fibrin/h. Protein was determined by the method of Lowry et al.  (23). 
Unless indicated otherwise, all results are shown as mean _+  SD for determinations on three 
replicate cultures. 
Materials.  Steroids  were  purchased  from  Sigma  Chemical  Co.,  St.  Louis,  Mo.,  Steraloids, 
Inc., Pawling,  N.  Y.,  or Calbiochem,  San Diego,  Calif.  Cortisone was recrystallized before use. 
Tissue culture media and supplements were obtained from Grand Island Biological Co.,  Grand 
Island,  N.  Y.  Multi-well  tissue  culture  dishes  tCostarl  were  purchased  from  Microbiological 
Associates, Walkersville, Md. Elastin from bovine ligamentum nuchae was obtained from Elastin 
Products,  Inc.,  St.  Louis,  Mo.  Latex  particles  were  purchased  from  Dow  Diagnostics,  Inc., 
Indianapolis, Ind. Anti-serum to sheep erythrocytes was purchased from Cordis Laboratories Inc., 
Miami, Fla.  TPCK-trypsin was purchased from Worthington Biochemical Corp., Freehold, N. J. 
M. lysodeikticus,  egg white lysozyme, and bovine fibrinogen were purchased from Sigma Chemical 
Co.  Brewer  thioglycollate  medium  was  purchased  from  Difco  Laboratories,  Detroit,  Mich. 
[:3H]NaBH4  was obtained from New England Nuclear,  Boston, Mass.  Nal~SI and [:~sS]methionine 
were purchased from Amersham Corp.,  Arlington Heights, Ill. All other reagents were obtained 
from standard sources. 
Results 
General  Considerations.  In  lymphocytes,  one  of  the  earliest  and  most 
striking effects of glucocorticoids is  a  change in cellular metabolism; glucose 
uptake  is  depressed,  ATP  economy  is  affected,  and  lactate  production  is 
decreased  (24). During culture of macrophages with glucocorticoids, the cells 
acidified their culture medium to a reduced extent as a function of glucocorticoid 
dose.  This  striking effect was  observed  in  all  macrophages  (human,  mouse, 
rabbit,  guinea pig) cultured at densities high enough to produce a  visible pH 
change in the medium, as monitored by phenol red indicator. The biochemical 
nature of the inhibition of the pH decrease has not been determined, but this 
inhibition alone could not account for the decrease in proteinase secretion that 
occurred.  When macrophages are treated with cytochalasin B  (3  tLM), glucose 
uptake decreases and the cells fail to acidify culture medium, but secretion of 
proteinases is not  inhibited (13, 251. A  small, but  consistent decrease in  CO., 
production  (15-20c2) was detected when stimulated mouse macrophages were 
treated with 10-1,000 nM dexamethasone. 
Even after 72 h of treatment, glucocorticoid concentrations of 1,000 nM or less 
were not toxic to macrophages; this contrasts with the lytic effects of glucocor- 
ticoids  on  lymphocytes  tl,  26,  27). Overall  protein  synthesis  measured  by 
incorporation of [:~sS]methionine  was not affected by glucocorticoids (0.1-1,000 1698  GLUCOCORTICOIDS INHIBIT MACROPHAOE  PROTEINASE  SECRETION 
nM dexamethasone), although specific changes in the patterns  of secreted and 
cellular  proteins  were  seen  (data  not  shown). Phagocytosis of either  latex 
particles  or IgG-coated sheep erythrocytes  was not  affected  by treatment  of 
mouse macrophages with up to 1,000 nM dexamethasone, as observed  previously 
in vitro (13, 28, 29). 
Effects of Glucocorticoids on Secretion of Neutral Proteinases by Stimulated 
Mouse Macrophages 
Macrophages elicited in vivo by various inflammatory stimuli secrete neutral 
proteinases and some other macromolecules at a  rate 3-100  times that of un- 
stimulated macrophages  (16, 20,  22,  30). Lysozyme, a  constitutive secretory 
product of m acrophages and a sensitive indicator of macrophage viability (21), is 
regulated by a different mechanism than elastase and other proteinases, and its 
secretion  was  not  affected  by  glucocorticoids.  Thioglycollate-elicited mouse 
peritoneal macrophages secreted lysozyme at the same rate in controls and cul- 
tures treated with dexamethasone (Fig. 1). 
GLUCOCORTICOIDS INHIBIT SECRETION OF NEUTRAL PROTEINASES.  In contrast to 
the observations with lysozyme, secretion of elastase, collagenase, and plasmino- 
gen activator was inhibited by addition of glucocorticoids to macrophage cultures. 
Dexamethasone inhibited secretion of elastase by thioglycollate-elicited macro- 
phages (Fig. 1). The inhibition of elastase secretion into the conditioned culture 
medium did not result in accumulation of the enzyme within the cells; elastase 
was present  in very low quantities in lysates of both control (22) and steroid- 
treated cells.  The decrease in elastase activity could not be attributed to an 
increased synthesis of an inhibitor of elastase activity in response to dexameth- 
asone;  inhibitor could not be  detected in  mixing experiments with partially 
purified macrophage elastase and medium from inhibited cultures, and treat- 
ment of the steroid-treated cells or conditioned medium with trypsin (10 ~g/ml, 
30 min at 25°C) did not activate a  latent form of the elastase. However, these 
data  do  not  preclude  the  possibility that  an  inactive  precursor  failed to  be 
secreted or converted to active enzyme as a result of steroid interaction with the 
cells. 
TIME  COURSE OF GLUCOCORTICOID INHIBITION.  The binding of dexamethasone 
to macrophages is complete within 30 min at 37°C (14). Steroid effects on plasmin- 
ogen activator production were not detected in the first 2 h of treatment with 1 
nM dexamethasone, but began to be seen at 2 h  with 100  nM  (Table I).  The 
inhibitory effect was both time and dose dependent. The inhibition was more 
pronounced at 20 h  of treatment than at 5 h.  Similarly, inhibition of elastase 
secretion was more pronounced at 12 h than at 6 h  (Table I). 
DIFFERENTIAL  EFFECTS  OF GLUCOCORTICOIDS ON  ELASTASE AND PLASMINOGEN  AC- 
TIVATOR.  Although the secretion of both elastase and plasminogen activator is 
increased after macrophage stimulation, the two enzymes are regulated inde- 
pendently, as shown by differential effects of colchicine (13, 25). One striking 
difference was  evident when the  inhibitory effects of dexamethasone on the 
secretion of plasminogen activator and elastase were compared  (Fig.  2).  The 
concentrations of dexamethasone giving half-maximum inhibition of the secre- 
tion  of these  two  enzymes  were  similar  (about  1  nM),  but  the  maximum ZENA  WERB  1699 
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FIG.  1.  Comparison of the  effects of dexamethasone on  the secretion of lysozyme and 
elastase by thioglycollate-elicited mouse peritoneal macrophages. Macrophages (0.8  ×  10e/ 
2-cm  2 well;  169  ~g of cell protein/well) were incubated for 48  h  in  DME-LH containing 
various concentrations of dexamethasone. Lysozyme (O) and elastase (O) activities in the 
conditioned culture media were determined. Results are shown as mean _+  SD (n =  3). 
TABLE  I 
Time Course of Dexamethasone  Inhibition of  Plasminogen Activator 
and Elastase Secretion by Thioglycollate-Elicited  Macrophages 
Enzyme 
Dexamethasone 
pretreatment 
time 
Enzyme secreted after dexameth- 
asone treatment 
1 nM  100 nM 
h  %  control 
Plasminogen  0  98  81 
activator*  5  68  32 
20  51  8 
Elastase$  6  91  64 
12  71  46 
* For plasminogen activator experiments, macrophages (2  x  105) were plated 
on  ~sI-fibrin-coated plates  for  24  h,  then  placed  in  DME  +  5%  ATDS-P 
containing 60  /zg of STI/ml and dexamethasone for the pretreatment time 
indicated. The cultures were then washed and placed in DME + 5% ATDS-P 
+  1 nM dog plasminogen with the appropriate dexamethasone concentra- 
tion. The 125I-fibrin hydrolysis was expressed as percentage of plasminogen- 
dependent degradation by control cultures. Control cultures secreted 43 U of 
plasminogen activator/106 cells/20 h, 
For elastase experiments, thioglycollate-elicited macrophages (2  x  10~/35  - 
mm-diameter plate) were placed in 1 ml of DME-LH containing the appro- 
priate concentration of dexamethasone for 6 or 12 h. Elastase secreted into 
the medium was expressed as percentage of elastase secreted by cultures 
without dexamethasone. Values are the means of 3 determinations. Control 
cultures secreted 2.8 U of elastase in 6 h and 6.8  U in 12 h. 1700  GLUCOCORTICOIDS  INHIBIT  MACROPHAGE  PROTEINASE  SECRETION 
O Elastase 
100  -¢,.-"~  •  Plasmmogen 
Activator 
-8 
~  80 
~g  60 
"~  ~  •  40  ~~~~___ 
20 
0  L..~q,  i  l  ~ 
0  10  -10  10  -9  10-8  10-7 
Dexamethasone Conc.  (M) 
Fro.  2.  Comparison of effects of dexamethasone on  elastase  and plasminogen activator 
secretion  by  thioglycollate-elicited  mouse  macrophages.  Macrophages  (2  x  10~/35-mm  - 
diameter well) were cultured in DME  +  10%  FCS for 48 h, washed 4 times in DME, then 
cultured in DME-LH in the presence of various concentrations of dexamethasone for 48 h. 
The enzyme activities in the conditioned  medium were  measured.  Macrophages cultured 
without  dexamethasone secreted  12.6  _+  1.2  U  of elastase and 117  ~-  18 U  of plasminogen 
activator  in  48  h.  Values  represent  the  mean  _~  SD  (n  =  3);  elastase  (O);  plasminogen 
activator (@).  Conc., concentration. 
inhibition of plasminogen activator secretion (97-100%) was greater than that 
for elastase  secretion  (65-80~£). Inhibition of elastase secretion was not com- 
plete, even after 120 h  in the presence of 1 ~M dexamethasone. Although it is 
possible that the elastase activity was due to the presence of two enzymes, one 
of which was glucocorticoid sensitive and the other insensitive, this is unlikely. 
The residual 20-35% of elastase secreted during steroid treatment had the same 
inhibitor profile as enzyme secreted by control cells.  This modulation, rather 
than total inhibition or induction of cellular proteins,  is characteristic of the 
effects of glucocorticoids in many other systems (1, 6, 24). 
GLUCOCORTICOID  INHIBITION  OF  MACROPHAGE  SECRETION  IS  REVERSIBLE.  After 
treatment with dexamethasone for 24 h, the secretion of elastase was restored 
to  at  least  80c~ of control  values  during  the  next  24  h.  For  plasminogen 
activator, reversal of the inhibitory effect of 10 nM dexamethasone was detected 
within 2 h  after removal of the drug by assay on fibrin plates, by single-cell 
assays with a casein overlay in the presence of plasminogen, and by conversion 
of l~I-plasminogen to l~5I-plasmin. 
INHIBITION  OF  MACROPHAGE  SECRETION  OF  PROTEINASE  IS  A  SPECIFIC  EFFECT  OF 
GLUCOCORTICOIDS.  Only  glucocorticoids  inhibited  secretion  of proteinases  by 
macrophages. Dexamethasone, cortisol, and corticosterone inhibited secretion of 
elastase  and  collagenase,  whereas  the  anti-glucocorticoids  (cortexolone  and 
progesterone),  a  glucocorticoid analogue (ll-epicortisol),  and the sex steroids 
had no inhibitory effects (Table II). 
PROGESTERONE  ANTAGONIZES  THE  GLUCOCORTICOID  INHIBITION  OF  MACROPI-IAGE 
SECRETION.  Progesterone has  no  glucocorticoid activity, although it competes ZENA  WERB  1701 
TABLE  II 
Effects of Various Steroids on Secretion of Elastase and Collagenase by 
Thioglycollate-Elicited Mouse Macrophages* 
Steroid  Concentration  Elastase secreted  Collagenase se- 
creted 
nM  U  mU 
None  -  18.3  -+ 3.6  119  ±  31 
Dexamethasone  10  n.d.  59  ±  7 
1,000  4.1  ±  0.2  0 
Cortisol  100  12.2  ±  0.2  77  ±  35 
1,000  8.5  -+ 0.7  22  ±  19 
Corticosterone  100  9.6  _+ 0.1  46  ±  23 
1,000  5.9  ±  0.7  0 
Cortexolone  100  15.4  _+ 2.0  n.d. 
1,000  12.9  _+  0.2  n.d. 
Progesterone  1,000  19.7  ±  1.3  96  -~ 26 
Cortisone  1,000  n.d.  104  ~  42 
ll-Epicortisol  100  21.0  _  4.5  n.d. 
Dihydrotestosterone  200  16.3  ±  1.1  n.d. 
Estradiol  500  20.2  _+ 0.9  127  _~ 41 
* Macrophages (3.2  ×  10") were plated  in DME  +  10~  FCS for 32  h, washed 4 times with 
DME, then placed  in 1.2  ml of DME-LH with steroids for 66 h. Collagenase was assayed 
after media were dialyzed  and  lyophilized,  reconstituted  at  0.1  of original  volume,  and 
then activated  with trypsin (n.d.,  not determined).  Values are shown as mean  ±  SD  (n 
=3). 
with glucocorticoids for receptor binding {14). Alone, progesterone had no effect on 
elastase  secretion;  in  combination  with  either  dexamethasone  or  cortisol, 
however,  progesterone blocked ~he glucocorticoid-mediated inhibition of elas- 
tase secretion (Fig. 3). 
The  Effect  of  Serum  on  Secretion  of  Plasminogen  Activator  and 
Elastase.  Secretion of both plasminogen activator and elastase by thioglycol- 
late-elicited mouse macrophages was detected in the presence of 5-10%  ATDS- 
P.  Serum  contains endogenous cortisol  and  progesterone,  but  there  was  no 
significant deviation in dose responsiveness of secretion between dexametha- 
sone with serum and dexamethasone without serum. Therefore, the steroids in 
dilute serum contributed little to the modulation of macrophage secretion. 
Effects  of  Glucocorticoids  on  Mouse  Monocytic  Precursor  Cells  and  on 
Unstimulated Peritoneal Macrophages 
DEXAMETHASONE  INHIBITS CELL  DIVISION DURING  FORMATION  OF  MONOCYTIC 
AND  GRANULOCYTIC  COLONIES FROM  MOUSE  BONE  MARROW  PRECURSOR  CELLS  IN 
VITRO.  The  anti-inflammatory effect of glucocorticoids is  reflected by  a  de- 
crease in mononuclear phagocytes in inflammatory exudates, and by a  severe 
monocytopenia (1-6);  it has been suggested that monocyte production is dimin- 
ished  by  an  inhibition  of promonocyte division  (5). Although glucocorticoid 
receptors have been studied only in monocytes and in later stages of mononu- 
clear phagocyte differentiation (14), the earliest accessible stage of macrophage 
differentiation that can be studied in vitro is the formation of monocytic and 
granulocytic colonies from committed bone marrow precursor cells. 1702  GLUCOCORTICOIDS  INHIBIT  MACROPHAGE  PROTEINASE  SECRETION 
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FIG.  3.  Antagonism by progesterone of the glucocorticoid inhibition of elastase secretion 
by thioglycollate-elicited mouse macrophages. Macrophages (2  x  l0  w) were cultured for 24 
h  in  DME  +  10~  FCS,  washed 4  times  in  DME,  then  placed  in  DME-LH  containing 
dexamethasone,  progesterone,  or  cortisol  at  various  concentrations for  48  h;  elastase 
activity of the conditioned media was then measured. Control macrophages incubated in 
DME-LH alone secreted 16.3 _~ 2.7 U ofelastase in 48 h. Values are means of  three replicate 
cultures. 
Dexamethasone reduced the number of CFU-C  that formed in vitro  (Table 
III).  After 7 days of incubation,  50%  inhibition of CFU-C  was  seen at  20 nM 
dexamethasone,  and  very  few  colonies  were  found  at  100  nM  or  higher 
concentrations.  However,  many clusters containing fewer than  50  cells were 
seen  at  several concentrations of the  steroid,  suggesting  that  the  decreased 
number of colonies was due to a  diminution in the rate of cell division, rather 
than to the lysis of the precursor cells. By 14 days of culture, a maximum of 50% 
inhibition  of CFU-C  formation was  observed  at  the  highest  dexamethasone 
concentration (1,000 nM). The cultures with 1,000 nM dexamethasone contained 
more  clusters  of cells  than  control cultures,  suggesting  that  the  number  of 
colonies in the treated cultures would approach the control level after further 
incubation. Both monocytic and granulocytic colonies were seen in control and 
dexamethasone-treated  cultures,  and  the  glucocorticoid  decreased  the  two 
populations proportionately (Table III).  Because cultures of bone marrow cells 
were heterogeneous, it could not be determined if the glucocorticoids acted on 
the  stem  cells  directly or  on  accessory cells  required  for differentiation and 
colony formation in vitro. 
GLUCOCORTICOIDS  INHIBIT SECRETION BY RESIDENT MOUSE PERITONEAL MAC- 
ROPHAGES.  Unstimulated macrophages secrete very small quantities of plas- 
minogen activator,  collagenase, or elastase (16,  20, 22, 30);  their  secretion of 
lysozyme  is comparable  to that  of stimulated  macrophages  (21) (i  x  i0" 
macrophages  secreted 2.2 ~g of lysozyme,  1.2 U  of elastase, and 4.3 U  of 
plasminogen activator  per 24 h). The ability  of  steroids  to modulate these basal 
levels  of  secretion was examined next. Extracellular secretion of  elastase and 
plasminogen  activator by  resident  macrophages  was  inhibited  79-97%  by 
glucocorticoids (100  nM dexamethasone, triamcinolone acetonide, and cortisol) ZENA  WERB  1703 
TABLE  III 
Effect of Dexamethasone  on Monocytic and Granulocytic  Colon)' (CFU-CJ Formation 
in Vitro* 
CFU-C type  Cell clusters  Dexameth-  Incubation  Total CFU-C ¢per 
asone  time  5 × 104 cells}  (per 5 × 10 ~ 
Monocytic  Granulocytic  cells} 
n  M  days 
0  7  9±2  62  ±5  54 ± 7  19 
14  8-+ 2  65  --6  107± 17  22 ± 2 
0.1  7  16 ± 5  60 ± 3  52±6  19 -~2 
14  9± 1  61  x6  112 ± 13  28±6 
1.0  7  12 ± 2  63  ± 6  56 ±6  24 ±3 
14  10-+2  61  ±5  108± 7  27 ± 4 
10  7  11-+ 3  74 ±9  37 ±8  44_+ 2 
14  7-+ 2  73 ~_3  90± 15  41± 4 
100  7  8±4  92 ± 4  5 ± 1  20 ±2 
14  10 ± 3  74 ± 2  71±9  48± 10 
1,000  7  0  100  1 ± 1  14 ± 8 
14  13 ±5  73-~  3  54+_9  43 ±9 
* Mean  ±  SE  ¢3  experiments,  each  in  duplicate;.  CFU-C  were 
granulocytic, or mixed. Percentage of mixed CFC-C is not shown. 
classified as described in Materials and Methods. 
designated  as  monocytic, 
Colonies and clusters were 
but  not  by  other  steroids  (100-1,000  nM  cortisone,  progesterone,  cortexolone, 
dihydrotestosterone,  ll-epicortisol),  whereas  lysozyme  secretion  was  not  af- 
fected by any of the steroids.  The concentration  of dexamethasone  giving half- 
maximum  inhibition of elastase  secretion  (2 nM)  (Fig.  4) was the  same  as the 
concentration that gave half-maximum  saturation  of the high affinity glucocor- 
ticoid  receptor  in  these  cells  (2.1  nM)  (14).  Cortisol  was  less  effective  as  an 
inhibitor,  reflecting its lower binding affinity for the  receptor  (14).  Cortisone, 
which does not bind to receptors,  reproducibly showed  a  small inhibitory effect 
on  elastase  secretion,  but  it is possible that  macrophages  convert  cortisone to 
cortisol at a  low rate. These results were quali.tatively similar to those obtained 
with stimulated  macrophages. 
Effects of Glucocorticoids on Mononuclear Phagocytes from Other Species 
Significant species differences exist in the responses of cells to glucocorticoids 
(1,  3)  and  in  secretion  of proteinases.  Accordingly,  macrophages  from  three 
other species were examined  to study the general applicability of the results of 
glucocorticoid treatment  of mouse cells. Human,  rabbit, and guinea  pig macro- 
phages all contained specific receptors for glucocorticoids (14). 
HUMAN BLOOD MONOCYTES.  Monocytes cultured on 125I-fibrin layers catalyze 
plasminogen-dependent  fibrinolysis at low rates (30). The production ofplasmin- 
ogen activator was inhibited by addition of dexamethasone  to the cultures.  As 
shown  in Table IV,  at 20 h  of treatment  the release of 12~I-labeled peptides was 
reduced to 42%  of control by  1  nM  dexamethasone,  and to  <10%  of control by 
100  nM;  estradiol,  dihydrotestosterone,  and  progesterone  had  no  effect  on 
production  of plasminogen  activator.  This  pattern  of steroid effects  correlates 
with the observed specificity and avidity of glucocorticoid binding to monocytes 
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FIo.  4.  Dose dependence  of glucocorticoid  inhibition on elastase secretion by  resident 
mouse peritoneal macrophages.  Macrophages  (6 × 10:'/2-cm  ~  well) were incubated with the 
steroids in DME-LH for 48 h,  and then elastase activity in the conditioned  media was 
determined.  Control  cells secreted  288  mU  of elastase  in  48  h.  Wells received  either 
dexamethasone (©), cortisol (0), or cortisone (~). Values are means of three wells, 
TABLE IV 
Effect of Various Steroids on Production  of Plasminogen 
Activator by Human  Monocytes 
~:~I-fibrin  degrada-  Added steroid  Concentration 
tion* 
nM  ~ control 
None  -  100 
Dexamethasone  1  41.3 
100  8.1 
Estradiol  100  109.9 
Dihydrotestosterone  100  94.8 
Progesterone  100  105.2 
Monocytes  (=5  ×  1051 were  cultured on  ~:5I-fibrin layers in  DME 
containing 5c~ ATDS-P with the steroid. The plasminogen-dependent 
fibrinolysis was measured after 20 h. Values are shown as mean of 3 
replicate cultures. Control cultures lysed  17.2% of the available l-'sI- 
fibrin / ~1 U of plaSminogen activatorl. 
RABBIT  ALVEOLAR MACROPHAGES.  Macrophages  from  the  granulomatous 
lungs of rabbits secreted several proteolytic enzymes that hydrolyzed collagen, 
fibrin, and elastin, and activated plasminogen at neutral pH. Two key features 
of  dexamethasone  inhibition of collagenase,  fibrinolytic proteinase,  elastase 
(Fig.  5),  and  plasminogen  activator  became  apparent.  Although  the  half- 
maximum  concentration (Kd) for dexamethasone binding to the  alveolar mac- 
rophages  was  1-3  nM,  the  concentrations of  dexamethasone  producing 50% 
inhibition of proteinase secretion were  as  low  as  0.05-0.1  nM,  and the  effects 
were seen at as little as 0.01 nM. Secondly, the four distinct proteolytic activities 
had different responses to the inhibitory effects of dexamethasone. The elastase 
(Fig.  5A)  was  inhibited  to  a  lesser  extent  than  the  collagenase,  neutral 
proteinase  (Fig.  5 B),  and plasminogen activator  (data  not shown),  even at  1 3 
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FIG.  5.  Effect  of dexamethasone on  secretion of proteinases by  adjuvant-elicited  rabbit 
alveolar macrophages. Macrophages were plated at 1.4  ×  10" cells/2-cm: well. (A) Secretion 
of elastase was studied by incubating macrophages in DME-LH containing dexamethasone 
for 96 h; conditioned culture media were then assayed for activity with 3H-labeled elastin- 
SDS as substrate.  Values are  shown as mean  z  SD  (n  =  3).  (B) Secretion of collagenase 
and  fibrinolytic  neutral  proteinase  was  examined  by  performing  enzyme  assays  on 
conditioned culture media after 48 h  incubation with dexamethasone. Values are shown as 
mean  _+  SD  (n  =  3).  Collagenase  activity  (J---G)  was  determined  with  radioactive 
collagen  fibrils as  substrate.  Neutral  proteinase  activity  (0  @)  was determined  with 
'~I-labeled fibrin as substrate. Conc., concentration. 
~M dexamethasone. Similarly, with mouse exudative macrophages, dexameth- 
asone  inhibited  plasminogen  activator  secretion  to  a  greater  degree  than 
elastase (Fig. 3). 
GUINEA PIG MACROPHAGES.  An  elastase-like proteinase was easily measured 
in the conditioned medium of guinea pig lung macrophages. Exposure of these 
macrophages to dexamethasone (10 nM) decreased production of this proteinase 
to  57%  of control  values.  These  inhibitory effects contrast  with the  relative 
insensitivity of guinea pig lymphocytes to the catabolic effects of glucocorticoids 
(1). 
Discussion 
Glucocorticoids  are  allosteric  effectors  which  regulate  differentiation and 
modulate physiological responses.  In macrophages and other target cells, the 
binding of the  glucocorticoid to  its  "cytosol" receptor  induces  an  "activated" 
state in the steroid receptor, which then acquires affinity for chromosomal sites 
(14,  31,  32). The  steroid-receptor  interaction  with  the  genome  triggers  the 
biological response  characteristic of the target  tissue.  Although the  receptor 
proteins  are  present  at  relatively  low  intracellular  concentrations  (~-5,000 
molecules per  macrophage  [14]), the behavior of the receptors can be  followed 
selectively because of their high specific affinity (I~,  =  1 nM) for the tritium- 
labeled hormone. The selectivity of the biological response may occur because 
productive  gene  activation is  achieved only when  receptor  molecules occupy 
multiple sites in the same genetic region (32). In the macrophage, genetic loci 
regulated by glucocorticoids have not been identified. 1706  GLUCOCORTICOIDS  INHIBIT  MACROPHAGE  PROTEINASE  SECRETION 
In this paper I have explored the action of glucocorticoids on key physiological 
functions of mononuclear  phagocytes in  culture.  The  most accessible effect of 
glucocorticoids on macrophage functions are inhibitory or catabolic, but gluco- 
corticoids can be anabolic as well (31). In general,  the molecular mechanisms 
for the catabolic effects of glucocorticoids are not as well understood as are the 
anabolic  or  inductive  effects.  Glucocorticoids  did  not  produce  measurable 
changes  in  overall  RNA  synthesis  of macrophages,  although  specific  effects 
probably occurred.  Overall  protein  synthesis by mouse  macrophages  was not 
affected  by glucocorticoids,  but  some  new  cellular  and  secreted  proteins  ap- 
peared,  and  other proteins decreased with dexamethasone  treatment  (unpub- 
lished  data).  Low concentrations  of dexamethasone  (0.4-40  nM)  induce  angi- 
otensin-converting enzyme in rabbit alveolar macrophages (33). 
Steroid-mediated  effects occurred  at  all  stages of macrophage  development 
tested,  from  the  differentiation  of committed  bone  marrow  stem  cells  into 
monocytes  to  the  metabolic  and  secretory  activity  of mature  macrophages 
responding to inflammatory  stimuli.  To assess the general  significance of the 
results described in this paper it is important to distinguish effects of glucocor- 
ticoids  that  are  responses  of eukaryotic  cells  in  culture  from  those  that  are 
specific to macrophages.  First, the proliferation of many cell types is regulated 
by glucocorticoids (26, 27, 31); however, macrophage differentiation shows some 
specificity  of response  both  in  vitro  and  in  vivo.  The  rate  of formation  of 
macrophage colonies from bone marrow stem cells was inhibited by dexameth- 
asone.  In  vivo  the  number  of circulating  monocytes  decreases  after  steroid 
treatment  (4,  5).  Low concentrations  of glucocorticoids  also  inhibit  granulo- 
poiesis as shown in this study and previously (34, 35), but potentiate erythropo- 
iesis (36). Second, plasminogen activators are produced by many cells, including 
monocytes  and  macrophages  (13,  18,  20,  30,  37).  Inhibition  of plasminogen 
activator synthesis and secretion by glucocorticoids at physiological concentra- 
tions  is not a  specific response of macrophages,  but  a  common feature of the 
regulation  of this  enzyme  in  many cell types  (13,  38,  39).  Third,  coll'agenase 
secretion by macrophages and by synovial cells, fibroblasts, and skin explants 
is inhibited by low concentrations  of dexamethasone  and other corticosteroids 
(18, 40, 41), which probably accounts for the slower rate of collagen degradation 
in granulomas in vivo in the presence of these steroids (42). Thus, the regulation 
of collagenase  production  by  glucocorticoids  is  not  unique  to  macrophages. 
Fourth,  secretion  of  macrophage  elastase  was  inhibited  by  glucocorticoids. 
Because secretion of macrophage  elastase  appears to be a  specific property of 
the mononuclear phagocyte series (unpublished data) its inhibition by glucocor- 
ticoids is a specific response of the macrophage. Finally, angiotensin-converting 
enzyme  is  induced  in  macrophages  by  glucocorticoids  (31).  This  enzyme  is 
produced by a number of cell types and its regulation by glucocorticoids in these 
cells has not been established. Although few of these responses to glucocorticoids 
are specific to macrophages, taken together, the spectrum of responsive proteins 
provides a distinctive profile or domain for the macrophage target cell. 
The inhibitory effects on proteinase secretion described could be either direct 
effects of glucocorticoids on genetic loci that control synthesis and processing of 
these  proteins  by  macrophages,  or  indirect  actions  on  loci  that  determine ZENA WERB  1707 
effector molecules,  which then  regulate  proteinase  secretion by macrophages. 
Prostaglandins,  which are  mediators of inflammation,  are  secreted by stimu- 
lated  macrophages  (43-45),  and  may  modulate  secretion  of collagenase  by 
guinea pig macrophages (43). In various cell types, production of prostaglandins 
is  inhibited  by glucocorticoids  (41,  46),  which  block the  release  of arachidonic 
acid from phospholipids (47).  It is possible that prostaglandins  mediate some of 
the effects of steroids on macrophages; however, it is unlikely that they account 
for all of the effects of glucocorticoids. Additions of exogenous prostaglandins or 
arachidonic  acid do not overcome the inhibition  by dexamethasone,  and indo- 
methacin,  an  inhibitor  of prostaglandin  synthetase,  does  not  have  the  pleio- 
morphic  effects  of glucocorticoids  on  physiological  functions  of macrophages 
(unpublished  data).  Other  regulatory  molecules  that  influence  macrophage 
functions may also be mediators of glucocorticoid action.  Lymphokines (44, 48), 
cyclic nucleotides (13), or proteinases secreted by the macrophages (48, 49) may 
mediate the inhibitory effects of glucocorticoids. Further investigation is neces- 
sary  to  assess the  relative  contribution  of these  factors  to  the  glucocorticoid 
responsiveness of macrophages. 
Because  products  of other  cells,  particularly  lymphocytes,  may  modulate 
macrophage  functions  such  as  secretion  (1,  8),  it  is  important  to  establish 
whether  or  not  glucocorticoids  act  directly  on  mononuclear  phagocytes.  Al- 
though macrophage populations are often considered homogeneous, the primary 
cultures are contaminated to varying degrees by small numbers of mesothelial 
cells, fibroblasts, and adherent lymphocytes (50, 51). In vivo, lymphocytes may 
be glucocorticoid target cells for functions expressed by macrophages  (1, 8).  In 
the overtly heterogeneous populations of bone marrow,  this question remains 
unresolved.  In  the  more  homogeneous  cultures  of peritoneal  and  alveolar 
macrophages,  it  is  likely  that  the  glucocorticoids  acted  directly,  because 
populations of macrophages contaminated  to varying degrees by nonadherent 
cells did not respond differently to the steroids. This interpretation  is supported 
by the observation of similar inhibitory effects of glucocorticoids on proteinase 
secretion  with  a  homogeneous  line  of macrophages  (P388D1),  derived  from  a 
tumor (52). 
In view of the inhibitory effects of glucocorticoids on macrophages at subphys- 
iological  concentrations  (e.g.,  Fig.  5),  the  degree  to  which  glucocorticoid- 
sensitive functions are expressed in vivo in the presence of potentially inhibitory 
concentrations of steroids is of interest.  Effective cortisol concentrations in vivo 
are modulated by the plasma-binding globulin, transcortin  (53), and by proges- 
terone,  an antiglucocorticoid (31, 54). In low concentrations of serum, secretion 
of plasminogen  activator  and  elastase  by thioglycollate-elicited  macrophages 
and formation of monocytic CFU-C were not affected,  and the  serum steroids 
did not interfere with the inhibitory effects of dexamethasone.  Effective inhibi- 
tion  of collagenase  secretion  by 1 nM  dexamethasone  in  10%  FCS  has  been 
reported  in  another  cell system  (41). Progesterone antagonized  the  inhibitory 
effects of exogenous glucocorticoids on proteinase  secretion,  as reported  here, 
and  on granulopoiesis  (34).  It  is probable that  physiological concentrations  of 
glucocorticoids, in the presence of physiological concentrations of progesterone, 
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Although  receptor  proteins  in  macrophages  have  a  binding  affinity  for 
dexamethasone of ~ 1 nM, glucocorticoid effects were observed at concentrations 
as low as 0.01  nM  in the present  work,  and  other glucocorticoid responses at 
subphysiological concentrations  have reported in  macrophages  (33,  34) and in 
other cells  (40,  41).  Thus,  undetected specific sites of even higher  affinity for 
glucocorticoids may exist,  as proposed for estradiol receptors (55).  An alterna- 
tive  explanation  is  that  the  specific  effects  are  initiated  when  only  a  few 
hormone-receptor complexes have bound to the genome at these low concentra- 
tions.  In most early studies of glucocorticoid effects on macrophages,  pharma- 
cological concentrations of steroids were used to achieve effects (4, 5, 8, 9, 11, 29, 
35, 56, 57). Because analysis of steroid receptors reveals no low affinity receptors 
specific for glucocorticoids (14), many of these effects are probably not receptor- 
mediated. 
Products  of macrophage  secretion  are  regulated  by  diverse  mechanisms. 
Lysozyme, a product that is secreted by macrophages in all states of stimulation 
(21),  was not affected by glucocorticoids.  Plasminogen  activator,  collagenase, 
and elastase are apparently secreted coordinately after macrophage stimulation 
in vivo and  in  vitro  (13,  16,  20-22) but are,  in fact, regulated by independent 
mechanisms. Plasminogen activator secretion is inhibited by colchicine (13) and 
prostaglandins  (unpublished data),  whereas elastase and collagenase secretion 
is stimulated by these drugs (25, 43, and unpublished data). Although secretion 
of these three proteinases was inhibited by glucocorticoids, differential sensitiv- 
ities were observed. In general,  plasminogen  activator secretion was inhibited 
to  a  greater extent  (>95%)  than  was elastase  secretion  (60-80%).  These  data 
support  classification  of  these  proteinases  into  separate  regulatory  groups 
sharing  a  few common  pathways.  Macrophages  have  been  shown  to  secrete 
several products in addition to lysozyme and the neutral proteinases.  Secretion 
of endogenous pyrogen (57) and lysosomal hydrolases (58) may also be inhibited 
by corticosteroids. The pathways for secretion of some complement components 
and proteinases have some similar regulatory sequences (59),  and it is possible 
that  complement proteins are also modulated by glucocorticoids.  Macrophages 
secrete both proteinases and proteinase inhibitors,  e.g.,  a:-macroglobulin  (60). 
The  regulation  of  a.,-macroglobulin  production  is  not  established,  but  it  is 
unlikely  that  changes  in  its  secretion  by  glucocorticoids  could  produce  the 
observed inhibition of proteinase secretion. 
Some metabolic functions were affected by glucocorticoids in the mononuclear 
phagocytes tested from four species (human,  mouse,  rabbit,  guinea  pig);  it is 
not clear, however, whether the spectrum of macrophage response is similar in 
all  species  and  in  all  tissues.  Although  the  concentration  of glucocorticoid 
receptors  decreased  with  increasing  state  of  macrophage  differentiation  or 
activation  (14),  monocytes, resident macrophages,  and exudative macrophages 
were  all  sensitive  to  glucocorticoids.  Similar  observations  in  lymphocytes 
suggest that increases in glucocorticoid receptor concentrations do not increase 
steroid  sensitivity  (61).  Mononuclear  phagocytes treated  with  glucocorticoids 
phenotypically  appear  to  be  less  differentiated  or  stimulated  than  untreated 
macrophages  in  their  secretion of proteinases  and  their  metabolism.  Further 
studies with glucocorticoids as probes may allow us to define the pathways of 
macrophage differentiation. ZENA  WERB  1709 
Summary 
The effects of glucocorticoids on biochemical functions of macrophages from 
man,  mouse, rabbit, and guinea pig were examined. Secretion of plasminogen 
activator by human peripheral blood monocytes was decreased by 50% with 1 
nM  dexamethasone.  Differentiation  of murine  monocytic  and  granulocytic 
colonies in agar from bone marrow precursors was decreased by 50% at 7 days 
with 20 nM dexamethasone. Secretion ofelastase, collagenase, and plasminogen 
activator by resident and thioglycollate-elicited mouse peritoneal macrophages 
was decreased by dexamethasone, cortisol, and triamcinolone acetonide (1-1,000 
nM), but not by progesterone, estradiol, and dihydrotestosterone (1,000 nM); in 
contrast,  secretion of lysozyme was  not  affected by  glucocorticoids or  other 
steroids.  The inhibition of macrophage secretion by dexamethasone was both 
time and dose dependent. Effects were detected within 1-6 h  after addition of 
the  glucocorticoids, became  maximum  by  24  h,  and  were  reversed during  a 
similar time period after removal of the hormones. The extentof inhibition of 
macrophage secretion increased with increasing glucocorticoid concentration. 
Half-maximum inhibition of secretion of elastase, collagenase, and plasmin- 
ogen activator was seen at dexamethasone concentrations (1-10 nM) similar to 
those that half-saturated the specific glucocorticoid receptors in these cells. At 
high concentrations of dexamethasone (100-1,000 nM) the secretion of plasmin- 
ogen activator was inhibited to a  greater extent (>95%) than the secretion of 
elastase (60-80%).  Progesterone alone had no effect on secretion, but it blocked 
the inhibitory effects of dexamethasone and cortisol. Secretion of collagenase, 
neutral  proteinases,  and  plasminogen  activator  by  elicited  rabbit  alveolar 
macrophages  was  inhibited  with  glucocorticoids  (0.1-100  nM)  but  not  with 
progesterone or sex steroids.  Secretion of a  neutral elastinolytic proteinase by 
guinea pig alveolar macrophages was also inhibited by dexamethasone. These 
data support the regulatory role of glucocorticoids on macrophage functions at 
physiological concentrations. 
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